Granules India’s Q4FY19 PAT up 78% yoy; stock trades flat

Granules India Ltd., a growing pharmaceutical manufacturing company, posted consolidated PAT higher by 78% at Rs236cr for Q4FY19. Total income for the fourth quarter of FY19 was Rs615cr, an increase of 20% from the same quarter of the previous financial year.

The Company’s Board of Directors has recommended a final dividend of 25 paise /share of the face value of Rs1 each in addition to the interim dividend of 75 paise /share already paid for the financial year 2019.

“I am pleased to see another quarter of continued growth in revenue and profit in fiscal 2019. We achieved this growth on the back of the inherent stability of the molecules in our portfolio combined with our relentless focus on efficient manufacturing. The primary Revenue growth driver for this quarter is the US formulation business, which complimented in an overall improvement in profitability margins compared with the same quarter of the previous financial year.

STOCK TIPS TODAY